Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-009256
Filing Date
2023-05-11
Accepted
2023-05-11 07:12:54
Documents
61
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q pasg-20230331x10q.htm   iXBRL 10-Q 1597221
2 EX-10.1 pasg-20230331xex10d1.htm EX-10.1 34570
3 EX-10.2 pasg-20230331xex10d2.htm EX-10.2 68022
4 EX-31.1 pasg-20230331xex31d1.htm EX-31.1 16646
5 EX-31.2 pasg-20230331xex31d2.htm EX-31.2 16154
6 EX-32.1 pasg-20230331xex32d1.htm EX-32.1 6338
7 EX-32.2 pasg-20230331xex32d2.htm EX-32.2 6371
8 GRAPHIC pasg-20230331x10q001.jpg GRAPHIC 71069
  Complete submission text file 0001558370-23-009256.txt   6311894

Data Files

Seq Description Document Type Size
9 EX-101.SCH pasg-20230331.xsd EX-101.SCH 40835
10 EX-101.CAL pasg-20230331_cal.xml EX-101.CAL 44106
11 EX-101.DEF pasg-20230331_def.xml EX-101.DEF 125659
12 EX-101.LAB pasg-20230331_lab.xml EX-101.LAB 381646
13 EX-101.PRE pasg-20230331_pre.xml EX-101.PRE 262931
55 EXTRACTED XBRL INSTANCE DOCUMENT pasg-20230331x10q_htm.xml XML 1015399
Mailing Address ONE COMMERCE SQUARE 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103
Business Address ONE COMMERCE SQUARE 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103 2678660312
Passage BIO, Inc. (Filer) CIK: 0001787297 (see all company filings)

EIN.: 822729751 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39231 | Film No.: 23908787
SIC: 2836 Biological Products, (No Diagnostic Substances)